Loading…
Apyx Medical Corporation is projected to rise to $5.72 by 2027, a +31% move from its current price of $4.38. APYX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $4.20 | $4.38 | $4.57 | +0.02% |
| Jul 14 | $4.13 | $4.38 | $4.65 | +0.05% |
| Jul 15 | $4.08 | $4.38 | $4.71 | +0.07% |
| Jul 16 | $4.04 | $4.38 | $4.76 | +0.09% |
| Jul 17 | $4.00 | $4.39 | $4.81 | +0.12% |
| Jul 18 | $3.96 | $4.39 | $4.85 | +0.14% |
| Jul 19 | $3.93 | $4.39 | $4.90 | +0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.93 | $4.39 | $4.90 | +0.16% |
| Week 2 | $3.76 | $4.39 | $5.13 | +0.33% |
| Week 3 | $3.64 | $4.40 | $5.32 | +0.49% |
| Week 4 | $3.54 | $4.41 | $5.49 | +0.66% |
| Week 5 | $3.46 | $4.42 | $5.64 | +0.82% |
| Week 6 | $3.38 | $4.42 | $5.79 | +0.98% |
| Week 7 | $3.32 | $4.43 | $5.92 | +1.15% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Apyx Medical Corporation is a healthcare company that designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. It operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). The company offers a helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures, and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures.
Its helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. The company also develops and manufactures OEM generators and related accessories. Apyx Medical Corporation was formerly known as Bovie Medical Corporation and changed its name in January 2019.
It was incorporated in 1982 and is based in Clearwater, Florida.
APYX is a healthcare stock trading at $4.50 with a market cap of $188.43M and is ranked 3853. The current price sits alongside a defined price outlook from the provided forecast, which shows gradual upside over time. The forecast for 2026 lists an average price of $4.50, with longer‑term averages expanding to $9.77 by 2030 and $59.01 by 2050, accompanied by rising ROIs across the horizon.
A major floor 36.3% below — a decisive break under it would weaken the trend.
The nearest floor, 13.5% below — buyers have tended to step in here.
The nearest ceiling, 11.0% above — a clean break opens room to run.
A major ceiling 23.6% above — clearing it would confirm fresh momentum.
Key APYX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of APYX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.35 | Buy | $4.37 | Buy |
| MA 10 | $4.44 | Sell | $4.37 | Buy |
| MA 20 | $4.36 | Buy | $4.34 | Buy |
| MA 50 | $4.08 | Buy | $4.17 | Buy |
| MA 100 | $3.88 | Buy | $3.97 | Buy |
| MA 200 | $3.70 | Buy | $3.59 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.80 | Neutral |
| Stoch RSI (14) | 37.90 | Neutral |
| CCI (20) | 7.08 | Neutral |
| Williams %R (14) | -45.59 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | 7.35 | Buy |
| Bollinger %B (20,2) | 0.52 | Neutral |
| Stochastic %K (14) | 54.41 | Neutral |
| TRIX (15) | 0.28 | Buy |
| Awesome (5,34) | 0.05 | Buy |
| Ultimate (7,14,28) | 49.92 | Neutral |
| Momentum (10) | 0.21 | Buy |
| Aroon Osc (25) | 16.00 | Buy |
| Hull MA (9) | 4.28 | Buy |
| ADX (14) | 9.82 | Neutral |
| ATR (14) | 0.17 | Info |
Technical sentiment is bullish overall, with RSI14 at 50. The 50‑day simple moving average is $3.96 and the 200‑day simple moving average is $3.58. Key near‑term levels include support at $3.79 and resistance at $4.86.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.79 | $4.38 | $6.14 | 0% | Neutral | |
| $4.34 | $5.72 | $8.10 | +31% | Bullish | |
| $4.27 | $5.89 | $8.79 | +34% | Bullish | |
| $5.54 | $7.93 | $12.33 | +81% | Bullish | |
| $7.87 | $11.66 | $18.73 | +166% | Bullish | |
| $8.78 | $13.42 | $22.20 | +207% | Bullish | |
| $10.09 | $15.89 | $26.98 | +263% | Bullish | |
| $10.12 | $16.38 | $28.46 | +274% | Bullish | |
| $10.11 | $16.82 | $29.84 | +284% | Bullish | |
| $12.30 | $21.01 | $38.02 | +380% | Bullish | |
| $18.99 | $36.62 | $71.91 | +736% | Bullish | |
| $41.30 | $91.78 | $202.34 | +20.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.79 | $4.38 | $5.21 | +0.00% |
| August 2026 | $3.70 | $4.43 | $5.48 | +1.09% |
| September 2026 | $3.70 | $4.47 | $5.63 | +1.05% |
| October 2026 | $3.54 | $4.32 | $5.52 | -3.37% |
| November 2026 | $3.58 | $4.41 | $5.70 | +2.03% |
| December 2026 | $3.79 | $4.70 | $6.14 | +6.61% |
Click any year to see its month-by-month APYX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The APYX price prediction for 2026 points to an average of $4.38 (low $2.79, high $6.14) — a potential gain of 0% on today's $4.38. A consolidation phase looks the most probable path here.
In 2027, APYX is projected to trade between $4.34 and $8.10, averaging $5.72 — a potential gain of +31% from today's $4.38. That is up +31% on the projected 2026 average. Momentum favours further upside here.
Apyx Medical Corporation's 2028 outlook centres on $5.89, within a $4.27 to $8.79 range. That is up +3% on the projected 2027 average. That marks a +34% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, APYX could reach as high as $12.33, with a base case around $7.93 and support toward $5.54 — roughly +81% from $4.38. Momentum favours further upside here.
Expect APYX to range from $7.87 to $18.73 through 2030. The $11.66 average target implies a +166% move from current prices. That is up +47% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The APYX price prediction for 2031 points to an average of $13.42 (low $8.78, high $22.20) — a potential gain of +207% on today's $4.38. Momentum favours further upside here.
In 2032, APYX is projected to trade between $10.09 and $26.98, averaging $15.89 — a potential gain of +263% from today's $4.38. That is up +18% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Apyx Medical Corporation's 2033 outlook centres on $16.38, within a $10.12 to $28.46 range. That is up +3% on the projected 2032 average. That marks a +274% change versus current levels. Momentum favours further upside here.
By 2034, APYX could reach as high as $29.84, with a base case around $16.82 and support toward $10.11 — roughly +284% from $4.38. Buyers look set to stay in control over this stretch.
Expect APYX to range from $12.30 to $38.02 through 2035. The $21.01 average target implies a +380% move from current prices. That is up +25% on the projected 2034 average. Momentum favours further upside here.
The APYX price prediction for 2040 points to an average of $36.62 (low $18.99, high $71.91) — a potential gain of +736% on today's $4.38. Buyers look set to stay in control over this stretch.
In 2050, APYX is projected to trade between $41.30 and $202.34, averaging $91.78 — a potential gain of +20.0x from today's $4.38. That is up +151% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in APYX today (≈ 228.310502 APYX) could be worth
$20,954.6
+$19,954.6 (+1995%) by 2050 · US Dollar
Based on the average projected APYX price of $91.78 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in APYXwould be worth at today's price.
$1,000 invested in APYX on Jul 10, 2025 (≈ 462.962945 APYX) would be worth
$2,027.78
+$1,027.78 (+102.8%) today · 2.03× · US Dollar
Based on a APYX entry price of $2.16 vs. today's $4.38.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.3 | $1,018.6 | +1.9% |
| 1 month ago | $4.61 | $950.11 | -5.0% |
| 3 months ago | $3.96 | $1,106.06 | +10.6% |
| 6 months ago | $4.01 | $1,092.27 | +9.2% |
| 1 year ago | $2.16 | $2,027.78 | +102.8% |
| All time (5.0y) ago | $9.36 | $467.95 | -53.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our APYX forecast.
Our base-case forecast reaches $8.80 around 2030.
Implied market cap at $8.80: $370.57M
The multi‑year forecast highlights a rising path for APYX. The 2026 average price is $4.50, with a max of $6.25 and a min of $2.79, and the 2026 ROI is 0% with a neutral sentiment. By 2030 the average is projected at $9.77 and the max at $15.64, delivering a 117.1% ROI and a bullish sentiment.
In 2040, the average is $26.30 with a max of $51.29, for a 484.4% ROI and continued bullish momentum. By 2050 the average is $59.01 and the max $129.09, reflecting a 1211.4% ROI and a bullish outlook. The sequence shows a sustained upside with bullish sentiment from 2027 onward, alongside progressively higher price targets and realized ROIs, though these figures are estimates and not guarantees.
Tap a question to reveal the answer.
Avg $9.77, min $6.62, max $15.64, ROI 117.1%. Sentiment: BULLISH.
The forecast shows rising averages and positive ROIs beyond 2026, with 2027 avg $5.38 (ROI 19.6%), 2028 avg $5.60 (ROI 24.4%), 2029 avg $6.95 (ROI 54.5%), 2030 avg $9.77 (ROI 117.1%), culminating in 2050 avg $59.01 (ROI 1211.4%). Sentiment shifts to BULLISH after 2026, suggesting upside potential, but these are estimates, not guarantees.
Yes. The forecast shows a max of $51.29 in 2040 and a max of $129.09 in 2050, indicating potential to exceed $50 by 2040 and again by 2050.
Current price is $4.50 and market cap is $188.43M.
For 2026, the min is $2.79, the avg is $4.50, the max is $6.25, with ROI 0% and sentiment NEUTRAL.
Apyx Medical Corporation Community Discussion
0Share your Apyx Medical Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.